FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition, namely a capsule for the treatment of disorders associated with infection Helicobacter pylori (H. pylori). A single dose capsule for the treatment of infections associated with infection Helicobacter pylori (H. pylori), including a mixture of: a first immediate release dosage composition in the form of compressed mini-tablets containing amoxicillin and rifabutin, and a second delayed-release dosage composition in the form of compressed mini-tablets containing omeprazole and coated with an enteric coating. A method for treating a host against infection H. Pylori.
EFFECT: above-described capsule can effectively treat disorders caused by Helicobacter pylori infection, by releasing drugs in a certain sequence.
19 cl, 6 dwg, 21 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING HIGH-BIOAVAILABILITY RIFABUTIN COMPOSITION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MYCOBACTERIOSIS | 2013 |
|
RU2520603C1 |
| COMPOSITION INHIBITING SECRETION OF ACID IN STOMACH | 2003 |
|
RU2340358C2 |
| PHARMACEUTICAL COMPOSITION, METHOD OF PREPARATION THEREOF, AND TREATMENT METHOD | 1993 |
|
RU2143899C1 |
| NEW FIELD OF COMPOUND APPLICATION AS ANTIMICTOBIAL AGENTS | 2000 |
|
RU2252032C2 |
| PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
| PHARMACEUTICAL COMPOSITION OF OMEPRAZOL | 2012 |
|
RU2647472C2 |
| CONTAINER OF MEDICINAL AGENTS FOR TREATMENT AND PROPHYLAXIS OF GASTROENTERIC DISEASES CAUSED OR MEDIATED BY INFECTION WITH HELICOBACTER PYLORI | 2002 |
|
RU2214819C1 |
| TENATOPAZOL (-)-ENANTIOMER, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND ITS USING | 2003 |
|
RU2310652C2 |
| PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
| MEDICINAL AGENT, PHARMACEUTICAL COMPOSITION, HELICOBACTER PYLORI GROWTH INHIBITOR AND METHOD OF ANTIHELICOBACTERY THERAPY | 2007 |
|
RU2367458C1 |
